Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Iowabio Innovation Showcase Now Accepting Applications

pfg_logo_rgb

IowaBio is now accepting applications for its Partnering for Growth Biotech Innovation Showcase.  The Showcase is an investor conference that allows emerging biotech companies to compete for a $5,000 grand prizeon March 21st in Ankeny, Iowa.  IowaBio is looking for applications from early-stage companies whose focus includes: Animal or Human Health Food, Ag or Plant Genetics Biofuels or Biomaterials Medical Technology Applications to present are being accepted through Jan. 6, 2017 at www.iowabio.org/pfgapply. A selection Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , ,

Happy 384th Birthday to the Father of Microbiology

leeuwenhoek_116x76

Today’s Google doodle celebrates the accomplishments of Antonie van Leeuwenhoek, the Father of Microbiology. In addition to being a remarkable DIYer, Leeuwenhoek is known to be the first to observe microorganisms, which he adorably referred to as “tiny animals,” through a microscope. From Leeuwenhoek’s discover, you can draw a direct line to the manipulation of microorganisms at the genetic and molecular level that we now refer to as biotechnology. A tip of the hat to Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , ,

MassBio Releases Statement Following Cost Trends Hearings

massbio_logo115

MassBio issues this statement, following the Massachusetts’ Health Policy Commission’s (HPC) hearing earlier this week on the cost and value of health care cost trends. BIO stands with MassBio in our commitment to addressing the true cost and value of innovative medical therapies and their place within cost containment efforts across the entire healthcare system today. Innovation in biopharmaceuticals saves lives. It also saves money. Every reduced hospital stay, every surgery avoided, every inoculation can help reduce Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

Patent Reform Needs to Address Trolling of All Stripes

uspto-madison-main-copy

As we enter the final days of the 114th Congress, it is regrettable that the unintended consequences of the PTO’s administrative patent challenge system known as Inter Partes Review, or IPR, continue to threaten innovative, intellectual property-reliant companies that are helping to drive this nation’s economic growth. It is vital that patent reform legislative efforts crack down on abuses of the IPR system and impose greater checks on the unfettered discretion of the PTO’s administrative Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Joins Biotech Week Activities

btw

Global Biotech Week is a week-long string of activities and events across the globe that exemplifies the increasing global cooperation of International Council of Biotech Associations members and other actors in the biotech world. The week aims to raise awareness and foster dialogue among all stakeholders on the science and the industry behind the products and processes enabled by this fantastic technology as well as on the challenges faced in ensuring these benefits reach citizens. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,